These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3328282)

  • 21. Sucralfate versus cimetidine in reflux oesophagitis. A double-blind clinical study.
    Elsborg L; Jørgensen F
    Scand J Gastroenterol; 1991 Feb; 26(2):146-50. PubMed ID: 2011701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of sucralfate in refractory reflux esophagitis. Results of a pilot study.
    Ros E; Pujol A; Bordas JM; Grande L
    Scand J Gastroenterol Suppl; 1989; 156():49-55. PubMed ID: 2740842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [2 or 1 daily doses of ranitidine in the treatment of reflux esophagitis].
    Rohner HG; Wienbeck M
    Z Gastroenterol; 1986 Aug; 24(8):396-402. PubMed ID: 3532593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reflux esophagitis therapy: sucralfate versus ranitidine in a double blind multicenter trial.
    Bremner CG; Marks IN; Segal I; Simjee A
    Am J Med; 1991 Aug; 91(2A):119S-122S. PubMed ID: 1882897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effect of sucralfate and ranitidine in reflux esophagitis.
    Simon B; Mueller P
    Am J Med; 1987 Sep; 83(3B):43-7. PubMed ID: 3310628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis.
    Williams RM; Orlando RC; Bozymski EM; Readling RD; Castell DO; Roufail WM; Rick GG; Rubin SE; Sinar DR
    Am J Med; 1987 Sep; 83(3B):61-6. PubMed ID: 3310630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of reflux oesophagitis. A randomized, controlled evaluation of cimetidine.
    Breen KJ; Desmond PV; Whelan G
    Med J Aust; 1983 Nov; 2(11):555-8. PubMed ID: 6355792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials.
    Koelz HR
    Scand J Gastroenterol Suppl; 1989; 156():25-36. PubMed ID: 2568015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sucralfate versus alginate/antacid in the treatment of peptic esophagitis.
    Evreux M
    Am J Med; 1987 Sep; 83(3B):48-50. PubMed ID: 2821808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of roxatidine acetate and ranitidine in the treatment of reflux esophagitis. The Roxatidine Esophagitis Study Group.
    Clin Ther; 1993; 15(2):283-93. PubMed ID: 8100189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Our experience in the treatment of reflux esophagitis with histamine H2 receptor antagonists].
    Cappelli J; Morobe J; Van Laethem A; Musin L
    Acta Chir Belg; 1983; 83(6):440-3. PubMed ID: 6318487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of sucralfate in peptic disease.
    Jensen SL; Funch Jensen P
    Dig Dis; 1992; 10(3):153-61. PubMed ID: 1611711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of peptic ulcers--acid reduction or cytoprotection?
    Glise H; Carling L; Hallerbäck B; Kagevi I; Solhaug JH; Svedberg LE; Wahlby L
    Scand J Gastroenterol Suppl; 1987; 140():39-47. PubMed ID: 3328284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sucralfate versus cimetidine in the treatment of reflux esophagitis in children.
    Argüelles-Martin F; Gonzalez-Fernandez F; Gentles MG
    Am J Med; 1989 Jun; 86(6A):73-6. PubMed ID: 2735338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recurrence of reflux esophagitis can be prevented with maintenance therapy with sucralfate].
    Tytgat GN; Koelz HR; Vosmaer GD
    Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2432-7. PubMed ID: 8524425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of ranitidine, domperidone maleate and ranitidine + domperidone maleate in the short-term treatment of reflux oesophagitis.
    Masci E; Testoni PA; Passaretti S; Guslandi M; Tittobello A
    Drugs Exp Clin Res; 1985; 11(10):687-92. PubMed ID: 3915459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. H2 antagonists in the treatment of reflux esophagitis: a critical analysis.
    Stalnikowicz-Darvasi R
    Am J Gastroenterol; 1989 Mar; 84(3):245-8. PubMed ID: 2563926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of reflux esophagitis with ranitidine. A multicentric prospective study].
    Koelz HR; Birchler R; Bron B; Delmore G; Frey M; Gonvers JJ; Halter F; Hammer B; Miller G; Realini S; Blum AL
    Schweiz Med Wochenschr; 1982 Dec; 112(51):1901-4. PubMed ID: 6298933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.